Clinical Trials Logo

Clinical Trial Summary

A multi-center, national prevalence study where: (1) baseline SPIVC therapy complications of hospitalized adult patients that meet the inclusion/exclusion criteria of the study and (2) the compliance of clinicians to the Hospital's evidence based practice will be measured in Brazil.


Clinical Trial Description

At each participating research site, select nurse clinicians who are experienced or experts in short peripheral I.V. catheter (SPIVC) therapy, will audit medical records and observe the SPIVC sites of adult patients in various hospital wards until a minimum total of 300 SPIVC sites are audited among 3 Brazilian acute care hospitals. The wards audited will be selected by the Investigator and will be audited during a specified time period until at least 100 SPIVCs are audited. The time to complete the study will depend on the size of the select wards, the number of nurse auditors and the number of monitoring visits required. There are no treatments. The short peripheral I.V. catheter-related medical devices (products) observed during the study are currently approved by Brazil regulatory agencies, purchased by the hospital and available to the clinician at the time of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03719287
Study type Observational
Source 3M
Contact
Status Completed
Phase
Start date January 7, 2019
Completion date October 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT03082066 - Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access